Literature DB >> 17589545

How Ebola and Marburg viruses battle the immune system.

Mansour Mohamadzadeh1, Lieping Chen, Alan L Schmaljohn.   

Abstract

The filoviruses Ebola and Marburg have emerged in the past decade from relative obscurity to serve now as archetypes for some of the more intriguing and daunting challenges posed by such agents. Public imagination is captured by deadly outbreaks of these viruses and reinforced by the specter of bioterrorism. As research on these agents has accelerated, it has been found increasingly that filoviruses use a combination of familiar and apparently new ways to baffle and battle the immune system. Filoviruses have provided thereby a new lens through which to examine the immune system itself.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589545     DOI: 10.1038/nri2098

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  55 in total

1.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Ebolavirus VP35 is a multifunctional virulence factor.

Authors:  Daisy W Leung; Kathleen C Prins; Christopher F Basler; Gaya K Amarasinghe
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

3.  Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Authors:  Travis K Warren; Kelly L Warfield; Jay Wells; Dana L Swenson; Kelly S Donner; Sean A Van Tongeren; Nicole L Garza; Lian Dong; Dan V Mourich; Stacy Crumley; Donald K Nichols; Patrick L Iversen; Sina Bavari
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

Review 4.  Bioterrorism and the Role of the Clinical Microbiology Laboratory.

Authors:  Elizabeth Wagar
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

5.  Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice.

Authors:  Wenfang Li; Ling Ye; Ricardo Carrion; Gopi S Mohan; Jerritt Nunneley; Hilary Staples; Anysha Ticer; Jean L Patterson; Richard W Compans; Chinglai Yang
Journal:  J Infect Dis       Date:  2015-04-14       Impact factor: 5.226

Review 6.  Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Authors:  Domenico Mattoscio; Chiara V Segré; Susanna Chiocca
Journal:  World J Virol       Date:  2013-05-12

7.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

8.  Understanding organ dysfunction in Ebola virus disease.

Authors:  Tom E Fletcher; Robert A Fowler; Nicholas J Beeching
Journal:  Intensive Care Med       Date:  2014-11-01       Impact factor: 17.440

9.  Point/counterpoint. Radiotherapy is an appropriate treatment to consider for patients infected with the Ebola virus.

Authors:  Wilfred F Ngwa; Roland Teboh; Colin G Orton
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

10.  Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.

Authors:  Cristian Cilloniz; Hideki Ebihara; Chester Ni; Gabriele Neumann; Marcus J Korth; Sara M Kelly; Yoshihiro Kawaoka; Heinz Feldmann; Michael G Katze
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.